Free online event – What Is Your Vision: The Future Of Abortion Care In Australia

Children by ChoiceFamily Planning NT, I Had One Too1800 My OptionsOur Bodies Our ChoicesSouth Australian Abortion Action CoalitionSexual Health Quarters WASPHERE and Women’s Health Tasmania, September 2020

What Is Your Vision: The Future Of Abortion Care In Australia Event Banner

Event time and date: Mon 28th Sep 2020, 7:00 pm – 8:15 pm AEST (NB: this event starts at 6.30 PM Adelaide Time)

About the event

Gina Rushton will be chatting to health consumers with lived experience, abortion care providers, advocates, policymakers, and you the audience about what the future of abortion care should and could look like in Australia.

This event will be exploring the Australian abortion landscape, recognising that each State and Territory has it’s own legal, cultural and practice context.

Our panellists:

  • Chrissie Bernasconi – Health Consumer
  • Dr Sarah McEwan – Wiradjuri woman and Medical Doctor
  • Hon Dr Sharman Stone – Professor of Practice for Gender, Peace and Security, Monash University
  • Dr Mark Farrugia – Rural GP and MTOP provider
  • Professor Deb Bateson – Medical Director, Family Planning NSW
  • Dr Suzanne Belton – Medical Anthropologist and Midwife

About the facilitator

Gina Rushton is a journalist who has written for BuzzFeed News, The Guardian, The Monthly, The Saturday Paper, Crikey, PRIMER and The Australian. She is a Royal Australian and New Zealand College of Obstetricians and Gynaecologists media excellence award winner and Australian Human Rights Commission media award finalist for her coverage of reproductive rights.

About International Safe Abortion Day

28th of September is International Safe Abortion Day, the herstory of this day begins in Latin America and the Caribbean where women’s groups have been mobilizing around September 28 for the last two decades to demand their governments decriminalize abortions, provide access to safe and affordable abortion services and to end stigma and discrimination towards people who choose to have abortions.

Extra info

There will be an opportunity to ask questions in a Q&A – You can also submit a question prior to the event when you register.

This event is offered in accordance with Children by Choice’s pro-choice framework. Children by Choice reserve the right to refuse registrations and remove individuals from the event.

Sex and gender: modifiers of health, disease, and medicine

The Lancet, Volume 396, Issue 10250, 22–28 August 2020, Pages 565-582
Mauvais-Jarvis, F., et al

Clinicians can encounter sex and gender disparities in diagnostic and therapeutic responses. These disparities are noted in epidemiology, pathophysiology, clinical manifestations, disease progression, and response to treatment. This Review discusses the fundamental influences of sex and gender as modifiers of the major causes of death and morbidity. We articulate how the genetic, epigenetic, and hormonal influences of biological sex influence physiology and disease, and how the social constructs of gender affect the behaviour of the community, clinicians, and patients in the health-care system and interact with pathobiology. We aim to guide clinicians and researchers to consider sex and gender in their approach to diagnosis, prevention, and treatment of diseases as a necessary and fundamental step towards precision medicine, which will benefit men’s and women’s health.

 

Online training: Hepatitis C in Primary Care

ASHM, August 2020

This training aims to provide participants with the knowledge and confidence to pursue the management of HCV in their primary care setting.

Primary care providers can play a critical role in the elimination of hepatitis C in Australia by 2030.

This workshop will provide an overview of the management of HCV in primary care
settings, including case finding, testing, patient assessment and treatment.

Learning Objectives:

• Identify priority populations for HCV screening
• Order and interpret tests appropriately to diagnose chronic HCV infection
• Describe the recommended pre-treatment assessment
• Demonstrate understanding of antiviral therapy for treatment of HCV
• Communicate confidently with patients about HCV

Webinar Presenter: Dr Alireza Ahmavand, General Practitioner, Arafura Medical Clinics – Casuarina

Target Audience:
General Practitioners, Nurse Practitioners, nurses, primary care-based practitioners
and other health care workers.

When: Wednesday 19 August 2020 7.30pm – 9.00pm AEST  (7 – 9.30 pm ACST)

Delivered online, free

This activity is allocated 3 activity points in the RACGP QI&CPD Program for the
2020-2022 Triennium.

For further details or assistance contact: Molly Stannard

 

Stigma towards people who inject drugs and sex workers prevalent, according to new Australian study

Centre for Social Research in Health, UNSW, July 2020

Priority groups at risk of blood borne viruses and sexually transmissible infections are still likely to experience negative behaviour from the general public and in healthcare settings according to a recent report from the Stigma Indicators Monitoring Project.

86% of the general public sampled self-reported that they would behave negatively towards people who inject drugs to some extent, as did 56% of healthcare workers and 55% of healthcare students. Additionally, 64% of the general public, and 36% and 31% of healthcare workers and students respectively, self-reported likely negative behaviour (to some extent) towards sex workers.

 

 

Medical Board releases new guidelines for practitioners and students on blood-borne viruses

Medical Board of Australia, 23 Jun 2020

The Medical Board of Australia is encouraging practitioners and students to review the new Guidelines for registered health practitioners and students in relation to blood-borne viruses before they take effect on 6 July 2020.

The Board’s guidelines are for practitioners and students who perform exposure-prone procedures and registered health practitioners who are treating registered health practitioners or students living with a blood-borne virus who perform exposure-prone procedures.

 

 

 

Sexual and reproductive health a COVID-19 priority (Statement)

Burnet Institute, 28 May, 2020

Burnet Institute is a member of a consortium of Australian-based non-governmental organisations (NGOs) and academic institutes concerned about the detrimental effects of the COVID-19 pandemic on the sexual and reproductive health and rights of women and girls globally.

The International Sexual and Reproductive Health and Rights Consortium, which includes Save the Children, Family Planning NSW, CARE Australia, The Nossal Institute for Global Health, and Médecins Sans Frontières Australia, is calling on the Australian Government to prioritise the needs of women and girls in its response to COVID-19.

Collectively, the consortium works across 160 countries to champion universal access to sexual and reproductive health and rights.

It’s concerned that women and girls across the globe are struggling to access critical sexual and reproductive health care, citing evidence that COVID-19 lockdowns are likely to cause millions of unplanned pregnancies.

In the Pacific, travel to rural and remote areas have been curtailed, and physical distancing requirements have forced the cancellation of most group training on sexual and reproductive rights.

A recent UNFPA report determined that a six-month lockdown could mean 47 million women and girls globally cannot access contraception, and seven million will become pregnant.

The consortium has issued a joint statement setting out priorities to ensure Australia’s global response to COVID-19 meets the critical needs of all women and girls, including:

  • Recognise and respond to the gendered impacts of the pandemic, and the increased risk to women and girls from gender-based violence and other harmful practices
  • Improve the supply of contraceptives and menstrual health products which are being impacted by the strain and disruption on global supply chains
  • Increase flexibility in delivering sexual and reproductive health services during lockdown using innovative health delivery models such as task-sharing, tele-health and pharmacy distribution
  • Support sexual and reproductive health workers and clinics to continue delivering services sagely with access to personal protective equipment as well as training on how to refer, test or diagnose COVID-19.